Junior Council Session

Engaged and Involved: Insights into cancer research.

Prof. Paul Workman

Discovery of Novel HSF1 Pathway Inhibitors: Chemical probes & a clinical candidate.

Dr. David Finlay

Fueling robust anti-tumour NK cell responses

Dr. Nuala McCabe

Using gene expression to analyze the Hallmarks of Cancer

Margaret Grayson

Survivorship: What does this mean to people affected by Cancer?

Dr. Noel McCaffrey

Community-based exercise in Cancer Survivorship

Dr. Robert O'Connor

Cancer Landscape in Ireland

Prof Peter Jones

Epigenetic Therapies

Irish Cancer Society

Present and past researchers who attended the conference

IACR 2019 Awards

We had an amazing 3-day event showcasing the exceptional cancer research being undertaken across the island of Ireland.

The 55th Annual Conference opened with a public event in honour of the late Professor Patrick (Paddy) G. Johnston QUB, where cancer researchers gave overviews of their research for a public forum.

We heard from national and internationally acclaimed speakers and gave awards to Phd students, Post Doctoral Fellows and team leaders who have excelled in their cancer research endeavours.

2019 Conference Programme

Exhibition Packages & Prices

Accompanying Delegate Info

Conference Speakers

Special Guest Speaker

Peter A. Jones, Ph.D, D.Sc. (hon)

Distinguished Professor and Director of the Center for Epigenetics

VARI Chief Scientific Officer
Van Andel Research Institute,
Grand Rapids, Michigan – USA

Peter Jones was born in Cape Town, raised and attended college in Rhodesia (now Zimbabwe), and received his Ph.D. from the University of London. He joined the University of Southern California in 1977 and served as Director of the USC Norris Comprehensive Cancer Center between 1993 and 2011.

He became Chief Scientific Officer of Van Andel Research Institute (VARI) in Grand Rapids, Michigan in 2014. His laboratory discovered the effects of 5-azacytidine on cytosine methylation and first established the link between DNA methylation, gene expression, and differentiation. He helped pioneer the field of epigenetics, particularly its role in cancer and helped develop novel therapies for cancer.

He has published more than 300 scientific papers and received several honors, including an Outstanding Investigator Award from the National Cancer Institute. He and his colleague Stephen Baylin shared the Kirk Landon Award for Basic Cancer Research from the AACR in 2009 and the Medal of Honor from the American Cancer Society in 2011.

Dr. Jones is a past President of the American Association for Cancer Research and was elected a Fellow of the American Association for the Advancement of Science in 2009 and a Fellow of the Academy of the AACR in 2013.

He was elected a member of the National Academy of Sciences of the United States in 2016, the American Academy of Arts and Sciences in 2017 and received an honorary Doctor of Science from Stellenbosch University in 2018.